Common Contracts
4 similar Underwriting Agreement contracts by Centene Corp
Centene Corporation Underwriting AgreementUnderwriting Agreement • October 28th, 2016 • Centene Corp • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $1,200,000,000 aggregate principal amount of its 4.75% Senior Notes due 2025 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc., Citigroup Global Markets Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will be issued pursuant to the indenture (the “Indenture”) to be dated as of November 9, 2016 between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). This agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters.
Centene Corporation Underwriting AgreementUnderwriting Agreement • June 14th, 2016 • Centene Corp • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $500,000,000 aggregate principal amount of its 4.75% Senior Notes due 2022 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Citigroup Global Markets Inc., Barclays Capital Inc., SunTrust Robinson Humphrey, Inc., and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will be issued pursuant to the indenture (the “Indenture”) dated as of April 29, 2014 between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). On April 29, 2014 and January 14, 2015, the Company issued $300,000,000 and $200,000,000, respectively, aggregate principal amount of the Company’s 4.75% Senior Notes due 2022 (collectively, the “Existing Notes”), in each case under the Indenture. The Notes constitute an offering of “Additional Notes” (as such term is defined in the Indenture) under the Indentur
Centene Corporation Underwriting AgreementUnderwriting Agreement • January 14th, 2015 • Centene Corp • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $200,000,000 aggregate principal amount of its 4.75% Senior Notes due 2022 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Citigroup Global Markets Inc., Barclays Capital Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will be issued pursuant to the indenture (the “Indenture”) dated as of April 29, 2014 between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). The Company previously issued $300,000,000 aggregate principal amount of the Company’s 4.75% Senior Notes due 2022 (the “Existing Notes”) under the Indenture. The Notes constitute an offering of “Additional Notes” (as such term is defined in the Indenture) under the Indenture. Except as disclosed in the Disclosure Package as of the Applicable Time and the Prospec
Centene Corporation Underwriting AgreementUnderwriting Agreement • April 29th, 2014 • Centene Corp • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $300,000,000 aggregate principal amount of its 4.75% Senior Notes due 2022 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will (i) have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section 1(a) hereof), (ii) be issued pursuant to an indenture (the “Indenture”) to be dated as of April 29, 2014 between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). This agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters.
